Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation
- PMID: 28232263
- DOI: 10.1016/j.hrthm.2017.01.038
Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation
Abstract
Background: Progression from paroxysmal to persistent atrial fibrillation (AF) has important clinical implications and is relevant to the management of patients with AF.
Objective: The purpose of this study was to define the long-term rate of progression from paroxysmal to persistent AF and the relevant clinical variables.
Methods: The Canadian Registry of Atrial Fibrillation enrolled patients after a first electrocardiographic diagnosis of paroxysmal AF. Associations between baseline characteristics and clinical outcomes were evaluated using a multivariable Cox proportional hazard model and a competing risk model accounting for death as a competing risk, where appropriate.
Results: We enrolled 755 patients (61.7% men) aged between 14 and 91 years (mean age 61.2 ± 14.2 years). The median follow-up was 6.35 years (interquartile range 2.93-10.04 years), with a rate of progression to persistent AF at 1, 5, and 10 years was 8.6%, 24.3%, and 36.3%, respectively. All-cause mortality was 30.3% at 10 years. Factors associated with AF progression were increasing age (hazard ratio [HR] 1.40; 95% confidence interval [CI] 1.23-1.60, for each 10-year increment), mitral regurgitation (HR 1.87; 95% CI 1.28-2.73), left atrial dilatation (HR 3.01; 95% CI 2.03-4.47), aortic stenosis (HR 2.40; 95% CI 1.05-5.48), and left ventricular hypertrophy (HR .47; 95% CI 1.04-2.08). Factors associated with a lower rate of progression were a faster heart rate during AF (HR 0.94; 95% CI 0.92-0.96 per 5-beat/min increment) and angina (HR 0.54; 95% CI 0.38-0.77). After accounting for death as a competing risk, left ventricular hypertrophy and aortic stenosis were no longer significant.
Conclusion: Within 10 years of presenting with paroxysmal AF, >50% of patients will progress to persistent AF or be dead. Increasing age, mitral regurgitation, aortic stenosis, left ventricular hypertrophy, and left atrial dilatation were associated with progression to persistent AF.
Keywords: Atrial fibrillation; Long-term follow-up; Paroxysmal; Persistent; Progression; Registry; Risk factors.
Copyright © 2017 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
Comment in
-
Atrial fibrillation progression: How sick is the atrium?Heart Rhythm. 2017 Jun;14(6):808-809. doi: 10.1016/j.hrthm.2017.02.027. Epub 2017 Mar 2. Heart Rhythm. 2017. PMID: 28259695 No abstract available.
Similar articles
-
Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation.Am Heart J. 2005 Mar;149(3):489-96. doi: 10.1016/j.ahj.2004.09.053. Am Heart J. 2005. PMID: 15864238
-
Long-term follow-up after catheter ablation of paroxysmal atrial fibrillation: the incidence of recurrence and progression of atrial fibrillation.Circ Arrhythm Electrophysiol. 2014 Apr;7(2):267-73. doi: 10.1161/CIRCEP.113.000471. Epub 2014 Mar 7. Circ Arrhythm Electrophysiol. 2014. PMID: 24610740
-
Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry.Chest. 2017 Dec;152(6):1266-1275. doi: 10.1016/j.chest.2017.08.004. Epub 2017 Aug 16. Chest. 2017. PMID: 28823813 Clinical Trial.
-
Incidence and predictors of atrial fibrillation progression: A systematic review and meta-analysis.Heart Rhythm. 2019 Apr;16(4):502-510. doi: 10.1016/j.hrthm.2018.10.022. Epub 2018 Oct 24. Heart Rhythm. 2019. PMID: 30366160
-
Pathophysiology of Paroxysmal and Persistent Atrial Fibrillation: Rotors, Foci and Fibrosis.Heart Lung Circ. 2017 Sep;26(9):887-893. doi: 10.1016/j.hlc.2017.05.119. Epub 2017 May 24. Heart Lung Circ. 2017. PMID: 28610723 Review.
Cited by
-
Progression from paroxysmal to persistent atrial fibrillation in pacemaker patients with tachycardia-bradycardia syndrome: a multicenter study.Heart Vessels. 2023 Sep;38(9):1149-1155. doi: 10.1007/s00380-023-02266-5. Epub 2023 Apr 7. Heart Vessels. 2023. PMID: 37029247
-
An echocardiographic model for predicting the recurrence of paroxysmal atrial fibrillation after circumferential pulmonary vein ablation.Clin Cardiol. 2021 Nov;44(11):1506-1515. doi: 10.1002/clc.23712. Epub 2021 Aug 11. Clin Cardiol. 2021. PMID: 34378199 Free PMC article. Clinical Trial.
-
Does Posterior Wall Isolation in Catheter Ablation of Persistent Atrial Fibrillation Change Clinical Outcomes?Arq Bras Cardiol. 2025 Feb 17;122(1):e20240815. doi: 10.36660/abc.20240815. eCollection 2025. Arq Bras Cardiol. 2025. PMID: 39968973 Free PMC article. English, Portuguese. No abstract available.
-
A machine learning-based model for predicting paroxysmal and persistent atrial fibrillation based on EHR.BMC Med Inform Decis Mak. 2025 Feb 3;25(1):51. doi: 10.1186/s12911-025-02880-5. BMC Med Inform Decis Mak. 2025. PMID: 39901121 Free PMC article.
-
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30. Circulation. 2024. PMID: 38033089 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical